Company: OSRH
Filing Date: 2025-01-29
Form Type: S-4/A
Source: 0001213900-25-007923
Chunk: 608

Company: OSR Holdings, Inc.
Filing Date: 2025-01-29
Form: S-4/A
Chunk 608
---
 the global economy, capital markets or other geopolitical conditions resulting from the Russian invasion of Ukraine, the escalation of the Israel -Hamasconflict and subsequent sanctions or related actions, could adversely affect the Company’s search for an initial business combination and any target business with which we may ultimately consummate an initial business combination. The excise tax included in the Inflation Reduction Act of 2022 may decrease the value of the Company’s securities following its initial business combination, hinder its ability to consummate an initial business combination, and decrease the amount of funds available for distribution in connection with a liquidation.

NOTE 6 — COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION

The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s balance sheets.

|                                                                         |     | Common     
 Stock      
 Subject to 
 Possible   
 Redemption |             |   |
|:------------------------------------------------------------------------|:----|:-----------|------------:|:--|
| Gross proceeds from Initial Public Offering                             |     | $          |  69,000,000 |   |
| Less: Proceeds allocated to public warrants and rights                  |     |            |  (1,236,527 | ) |
| Offering costs allocated to common stock subject to possible redemption |     |            |  (4,791,126 | ) |
| Less: Redemption of common stock in connection with Trust extension     |     |            | (35,995,728 | ) |
| Plus: Accretion on common stock subject to possible redemption          |     |            |   9,449,634 |   |
| Balance, December 31, 2023                                              |     | $          |  36,426,253 |   |

F-44 BELLEVUE LIFE SCIENCES ACQUISITION CORP.
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2023 NOTE 7 — STOCKHOLDERS’ DEFICIT Preferred Stock The Company is authorized to issue 1,000,000shares of preferred stock with a par value of $ 0.0001per share. As of December31, 2023 and 2022, there were noshares of preferred stock issued or outstanding. Common Stock Pursuant to the Amended and Restated Certificate of Incorporation, the